TOO 2017-08-22T05:29:19+00:00

Tissue of Origin® Test

Tissue of Origin®

The Tissue of Origin (TOO) test is a microarray-based gene expression test that aids in identifying challenging tumors, including metastatic, poorly differentiated and undifferentiated cancers. TOO is the ONLY FDA-cleared test of its kind.

The TOO test originally developed by Pathwork Diagnostics is now available through our partners Cancer Genetics Inc. TOO test is offered exclusively in India and South Asia by Sayre Therapeutics.

If you want to know more about the test, please contact your local Sales Representative in India
or email us at